173 related articles for article (PubMed ID: 37308430)
21. [MIR503HG promotes esophageal squamous cell carcinoma cell proliferation, invasion and migration via hsa-miR-503 pathway].
Gong TY; Chen HY; Liu ZH
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1160-1167. PubMed ID: 36380664
[No Abstract] [Full Text] [Related]
22. Inhibition of bromodomain-containing protein 4 enhances the migration of esophageal squamous cell carcinoma cells by inducing cell autophagy.
Yang WQ; Liang R; Gao MQ; Liu YZ; Qi B; Zhao BS
World J Gastrointest Oncol; 2022 Dec; 14(12):2340-2352. PubMed ID: 36568944
[TBL] [Abstract][Full Text] [Related]
23. Metformin Inhibited Growth, Invasion and Metastasis of Esophageal Squamous Cell Carcinoma in Vitro and in Vivo.
Liang F; Wang YG; Wang C
Cell Physiol Biochem; 2018; 51(3):1276-1286. PubMed ID: 30481793
[TBL] [Abstract][Full Text] [Related]
24. [En1 promotes cell proliferation and migration via Hedgehog signaling pathway in esophageal squamous cell carcinoma].
Zhao N; Gong TY; Wei ZC; Cong J; Liu ZH; Chen HY
Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):99-107. PubMed ID: 38418183
[No Abstract] [Full Text] [Related]
25. BMI-1 suppression increases the radiosensitivity of oesophageal carcinoma via the PI3K/Akt signaling pathway.
Yang XX; Ma M; Sang MX; Zhang XY; Liu ZK; Song H; Zhu SC
Oncol Rep; 2018 Feb; 39(2):667-678. PubMed ID: 29207170
[TBL] [Abstract][Full Text] [Related]
26. [Knockdown of MTA1 inhibits the proliferation and apoptosis of esophageal cancer cells].
Yu YY; Zhao J; Li XN
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):197-202. PubMed ID: 32252197
[No Abstract] [Full Text] [Related]
27. DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis.
Ji YM; Zhou XF; Zhang J; Zheng X; Li SB; Wei ZQ; Liu T; Cheng DL; Liu P; Song K; Tan T; Zhu H; Guo JL
Oncotarget; 2016 Mar; 7(12):14188-98. PubMed ID: 26893358
[TBL] [Abstract][Full Text] [Related]
28. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway.
Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W
Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623
[TBL] [Abstract][Full Text] [Related]
29. [Effects of microRNA-182-5p on cell proliferation and invasion of esophageal squamous cell carcinoma and related molecular mechanisms].
Zhu ZQ; Hu HF; Zheng XY; Wang F
Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):635-643. PubMed ID: 32867454
[No Abstract] [Full Text] [Related]
30. Raltitrexed enhanced antitumor effect of anlotinib in human esophageal squamous carcinoma cells on proliferation, invasiveness, and apoptosis.
Zhen H; Tian J; Li G; Zhao P; Zhang Y; Che J; Cao B
BMC Cancer; 2023 Mar; 23(1):207. PubMed ID: 36870981
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma.
Hao XW; Zhu ST; He YL; Li P; Wang YJ; Zhang ST
World J Gastroenterol; 2012 Feb; 18(6):532-40. PubMed ID: 22363119
[TBL] [Abstract][Full Text] [Related]
32. Sporoderm-Removed
Liu G; Zeng T
Integr Cancer Ther; 2021; 20():15347354211062157. PubMed ID: 34841952
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-21 promotes the proliferation and inhibits apoptosis in Eca109 via activating ERK1/2/MAPK pathway.
Liu F; Zheng S; Liu T; Liu Q; Liang M; Li X; Sheyhidin I; Lu X; Liu W
Mol Cell Biochem; 2013 Sep; 381(1-2):115-25. PubMed ID: 23709326
[TBL] [Abstract][Full Text] [Related]
34. Bufalin suppresses esophageal squamous cell carcinoma progression by activating the PIAS3/STAT3 signaling pathway.
Ju Q; Shi Q; Liu C; Fu G; Shi H
J Thorac Dis; 2023 Apr; 15(4):2141-2160. PubMed ID: 37197494
[TBL] [Abstract][Full Text] [Related]
35. Skimmianine as a novel therapeutic agent suppresses proliferation and migration of human esophageal squamous cell carcinoma via blocking the activation of ERK1/2.
Liu Y; Kang L; Shi SM; Li BJ; Zhang Y; Zhang XZ; Guo XW; Fu G; Zheng GN; Hao H; Zhao HF
Neoplasma; 2022 May; 69(3):571-582. PubMed ID: 35144474
[TBL] [Abstract][Full Text] [Related]
36. PIK3CA promotes proliferation and motility but is unassociated with lymph node metastasis or prognosis in esophageal squamous cell carcinoma.
Zheng S; Yang C; Lu M; Liu Q; Liu T; Dai F; Gao X; Sheyhidin I; Lu X
Hum Pathol; 2016 Jul; 53():121-9. PubMed ID: 27001433
[TBL] [Abstract][Full Text] [Related]
37. miR-18a promotes cell proliferation of esophageal squamous cell carcinoma cells by increasing cylin D1 via regulating PTEN-PI3K-AKT-mTOR signaling axis.
Zhang W; Lei C; Fan J; Wang J
Biochem Biophys Res Commun; 2016 Aug; 477(1):144-149. PubMed ID: 27291152
[TBL] [Abstract][Full Text] [Related]
38. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X
Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239
[TBL] [Abstract][Full Text] [Related]
39. HMGB1 induces radioresistance through PI3K/AKT/ATM pathway in esophageal squamous cell carcinoma.
Zhang X; Zou N; Deng W; Song C; Yan K; Shen W; Zhu S
Mol Biol Rep; 2022 Dec; 49(12):11933-11945. PubMed ID: 36260180
[TBL] [Abstract][Full Text] [Related]
40. OPN Promotes Cell Proliferation and Invasion through NF-
Chen B; Liang S; Guo H; Xu L; Li J; Peng J
Genet Res (Camb); 2022; 2022():3154827. PubMed ID: 36619897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]